Cargando…
De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD
BACKGROUND: Von Willebrand disease (VWD) is not uncommon in Taiwan. In type 2 or type 3 VWD hemorrhagic symptoms are severer and laboratory data relatively more distinctive. De novo mutation and somatic mosaicism of type 2 VWD gene were rarely reported. Therefore clinical, laboratory and genetic stu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056463/ https://www.ncbi.nlm.nih.gov/pubmed/27766062 http://dx.doi.org/10.1186/s12959-016-0092-2 |
_version_ | 1782458904479793152 |
---|---|
author | Shen, Ming-Ching Chen, Ming Ma, Gwo-Chin Chang, Shun-Ping Lin, Ching-Yeh Lin, Bo-Do Hsieh, Han-Ni |
author_facet | Shen, Ming-Ching Chen, Ming Ma, Gwo-Chin Chang, Shun-Ping Lin, Ching-Yeh Lin, Bo-Do Hsieh, Han-Ni |
author_sort | Shen, Ming-Ching |
collection | PubMed |
description | BACKGROUND: Von Willebrand disease (VWD) is not uncommon in Taiwan. In type 2 or type 3 VWD hemorrhagic symptoms are severer and laboratory data relatively more distinctive. De novo mutation and somatic mosaicism of type 2 VWD gene were rarely reported. Therefore clinical, laboratory and genetic studies of only type 2A, 2B and 2M VWD will be presented and issues of de novo mutation and somatic mosaicism will be explored. METHODS: Fifty-four patients belonging to 23 unrelated families from all around the country in whom type 2 VWD exclusive of type 2N has been diagnosed not only by clinical and routine laboratory studies but also by genetic confirmation during 1990–2015 were investigated. A novel technique named amplification refractory mutation system-quantitative polymerase chain reaction (ARMS-qPCR) was used to confirm the presence of somatic mosaicism. Informed consent was obtained for study. RESULTS: De novo mutation was identified in 4 families among 15 families (26.7 %) in whom family members including parents were available for examination. All their parents were free from bleeding symptoms and had no similar mutation as their respective affected daughter. An interesting example of somatic mosaicism of VWF gene mutation was found in a large family with type 2A VWD. The father carrying a mutated VWF gene, p.Arg1597Trp, transmitted this mutation to his 3 daughters, 1 son, 3 granddaughters and 2 grandsons. However, the father had normal laboratory findings and experienced no abnormal bleeding, while his offspring who inherited the mutation showed abnormal laboratory findings compatible with type 2A VWD and had history of abnormal bleedings. ARMS-qPCR revealed that the father had only 25.5 % mutant in his blood cells and 31.1 % mutant in his oral mucosal cells, while all his offspring had about 49 % mutant in their blood cells. CONCLUSION: De novo mutation of type 2 VWD gene was identified in 4 out of 15 families (26.7 %) examined. Since only one child was affected in each family, germline mosaicism was not likely. A somatic mosaicism of type 2A VWD gene was documented in a big family by a newly in-house developed technique ARMS-qPCR. |
format | Online Article Text |
id | pubmed-5056463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50564632016-10-20 De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD Shen, Ming-Ching Chen, Ming Ma, Gwo-Chin Chang, Shun-Ping Lin, Ching-Yeh Lin, Bo-Do Hsieh, Han-Ni Thromb J Research BACKGROUND: Von Willebrand disease (VWD) is not uncommon in Taiwan. In type 2 or type 3 VWD hemorrhagic symptoms are severer and laboratory data relatively more distinctive. De novo mutation and somatic mosaicism of type 2 VWD gene were rarely reported. Therefore clinical, laboratory and genetic studies of only type 2A, 2B and 2M VWD will be presented and issues of de novo mutation and somatic mosaicism will be explored. METHODS: Fifty-four patients belonging to 23 unrelated families from all around the country in whom type 2 VWD exclusive of type 2N has been diagnosed not only by clinical and routine laboratory studies but also by genetic confirmation during 1990–2015 were investigated. A novel technique named amplification refractory mutation system-quantitative polymerase chain reaction (ARMS-qPCR) was used to confirm the presence of somatic mosaicism. Informed consent was obtained for study. RESULTS: De novo mutation was identified in 4 families among 15 families (26.7 %) in whom family members including parents were available for examination. All their parents were free from bleeding symptoms and had no similar mutation as their respective affected daughter. An interesting example of somatic mosaicism of VWF gene mutation was found in a large family with type 2A VWD. The father carrying a mutated VWF gene, p.Arg1597Trp, transmitted this mutation to his 3 daughters, 1 son, 3 granddaughters and 2 grandsons. However, the father had normal laboratory findings and experienced no abnormal bleeding, while his offspring who inherited the mutation showed abnormal laboratory findings compatible with type 2A VWD and had history of abnormal bleedings. ARMS-qPCR revealed that the father had only 25.5 % mutant in his blood cells and 31.1 % mutant in his oral mucosal cells, while all his offspring had about 49 % mutant in their blood cells. CONCLUSION: De novo mutation of type 2 VWD gene was identified in 4 out of 15 families (26.7 %) examined. Since only one child was affected in each family, germline mosaicism was not likely. A somatic mosaicism of type 2A VWD gene was documented in a big family by a newly in-house developed technique ARMS-qPCR. BioMed Central 2016-10-04 /pmc/articles/PMC5056463/ /pubmed/27766062 http://dx.doi.org/10.1186/s12959-016-0092-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Shen, Ming-Ching Chen, Ming Ma, Gwo-Chin Chang, Shun-Ping Lin, Ching-Yeh Lin, Bo-Do Hsieh, Han-Ni De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD |
title | De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD |
title_full | De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD |
title_fullStr | De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD |
title_full_unstemmed | De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD |
title_short | De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD |
title_sort | de novo mutation and somatic mosaicism of gene mutation in type 2a, 2b and 2m vwd |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056463/ https://www.ncbi.nlm.nih.gov/pubmed/27766062 http://dx.doi.org/10.1186/s12959-016-0092-2 |
work_keys_str_mv | AT shenmingching denovomutationandsomaticmosaicismofgenemutationintype2a2band2mvwd AT chenming denovomutationandsomaticmosaicismofgenemutationintype2a2band2mvwd AT magwochin denovomutationandsomaticmosaicismofgenemutationintype2a2band2mvwd AT changshunping denovomutationandsomaticmosaicismofgenemutationintype2a2band2mvwd AT linchingyeh denovomutationandsomaticmosaicismofgenemutationintype2a2band2mvwd AT linbodo denovomutationandsomaticmosaicismofgenemutationintype2a2band2mvwd AT hsiehhanni denovomutationandsomaticmosaicismofgenemutationintype2a2band2mvwd |